A MODERN VIEW ON THE CLASSIFICATION AND DIAGNOSIS OF THE OPEN ARTERIAL DUCT (REVIEW)

  • L.Yu. Artyukh Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
  • N.R. Karelina Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
  • M.D.L. Oppedisano Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
  • M.R. Gafiatulin Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
  • O.L. Krasnogorskaya Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
  • N.A. Sidorova Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
  • E.V. Yatsenko Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
  • E.S. Kulemin Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
Keywords:
открытый артериальный проток эпидемиология классификация диагностика фетальные коммуникации анатомия patent arterial duct anatomy epidemiology classification diagnostics fetal communications

Abstract

We have analyzed domestic and foreign sources, on the basis of which a variant of systematization of the existing author’s classifications of the patent arterial duct (PAD) is proposed and the main diagnostic studies used to identify a functioning duct are described. Mandatory diagnostic measures for suspected PAD include assessment of the clinical picture (subjective and objective examination data) as well as non-invasive methods (radiography, electrocardiography, echocardiography, including three-dimensional variant, multispiral computed tomography (MCT), perfusion
index, and infrared spectroscopy). The important role of laboratory diagnostic methods was noted: it was shown that the level of plasma B-type natriuretic peptide (NT-proBNP) and the level of cardiac troponin T (cTnT) can be used as biomarkers indicating the presence of PAD and allowing the determination of treatment approaches.

Most read articles by the same author(s)